NanoMedesil (Q3679109)

From EU Knowledge Graph
Revision as of 14:45, 26 November 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in de: translated_label)
Jump to navigation Jump to search
Project Q3679109 in France
Language Label Description Also known as
English
NanoMedesil
Project Q3679109 in France

    Statements

    0 references
    59,500.0 Euro
    0 references
    88,835.0 Euro
    0 references
    66.98 percent
    0 references
    20 November 2015
    0 references
    30 June 2018
    0 references
    CNRS Délégation Languedoc Roussillon
    0 references
    0 references
    Le projet NanoMedesil vise à exploiter les propriétés particulières du silicium poreux, qui est l'un des rares nanomatériaux bio résorbable et non toxique, afin d'élaborer des systèmes utilisables en imagerie médicale, en thérapie anti-tumorale ciblée et pour la régénération tissulaire dans le traitement du cancer. Ce projet s'appuie sur une démarche de recherche innovante et est susceptible de générer une innovation de produit, à travers l'application clinique des nano-outils thérapeutiques développés au niveau préclinique et l'élaboration d'un nouveau produit médical avancé. (French)
    0 references
    The NanoMedesil project aims to exploit the unique properties of porous silicon, one of the few bioresorbable and non-toxic nanomaterials, to develop systems for medical imaging, targeted anti-tumor therapy and tissue regeneration in the treatment of cancer. This project is based on an innovative research approach and is likely to generate product innovation, through the clinical application of therapeutic nano-tools developed at preclinical level and the development of a new advanced medical product. (English)
    18 November 2021
    0 references

    Identifiers

    LR0001323
    0 references